NCT03805750: A trial that was reported late by University of California, San Diego
This trial has reported, although it was 167 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03805750 |
|---|---|
| Title | A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET). |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 22, 2019 |
| Completion date | Sept. 1, 2020 |
| Required reporting date | Sept. 1, 2021, midnight |
| Actual reporting date | Feb. 15, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 167 |